Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-07

AUTHORS

M Diaz, J J Kim, G Albero, S de Sanjosé, G Clifford, F X Bosch, S J Goldie

ABSTRACT

Cervical cancer is a leading cause of cancer death among women in low-income countries, with approximately 25% of cases worldwide occurring in India. We estimated the potential health and economic impact of different cervical cancer prevention strategies. After empirically calibrating a cervical cancer model to country-specific epidemiologic data, we projected cancer incidence, life expectancy, and lifetime costs (I$2005), and calculated incremental cost-effectiveness ratios (I$/YLS) for the following strategies: pre-adolescent vaccination of girls before age 12, screening of women over age 30, and combined vaccination and screening. Screening differed by test (cytology, visual inspection, HPV DNA testing), number of clinical visits (1, 2 or 3), frequency (1 x , 2 x , 3 x per lifetime), and age range (35-45). Vaccine efficacy, coverage, and costs were varied in sensitivity analyses. Assuming 70% coverage, mean reduction in lifetime cancer risk was 44% (range, 28-57%) with HPV 16,18 vaccination alone, and 21-33% with screening three times per lifetime. Combining vaccination and screening three times per lifetime provided a mean reduction of 56% (vaccination plus 3-visit conventional cytology) to 63% (vaccination plus 2-visit HPV DNA testing). At a cost per vaccinated girl of I$10 (per dose cost of $2), pre-adolescent vaccination followed by screening three times per lifetime using either VIA or HPV DNA testing, would be considered cost-effective using the country's per capita gross domestic product (I$3452) as a threshold. In India, if high coverage of pre-adolescent girls with a low-cost HPV vaccine that provides long-term protection is achievable, vaccination followed by screening three times per lifetime is expected to reduce cancer deaths by half, and be cost-effective. More... »

PAGES

6604462

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6604462

DOI

http://dx.doi.org/10.1038/sj.bjc.6604462

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1038043563

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18612311


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cost-Benefit Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Human papillomavirus 16", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Human papillomavirus 18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "India", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mass Screening", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Economic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Statistical", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Papillomavirus Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Papillomavirus Vaccines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stochastic Processes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Uterine Cervical Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vaccination", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Autonomous University of Barcelona", 
          "id": "https://www.grid.ac/institutes/grid.7080.f", 
          "name": [
            "Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Av. Gran Via, s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Spain", 
            "Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor; Boston, MA 02115, USA", 
            "Department of Paediatrics, Obstetrics, Gynaecology and Preventive Medicine, Program in Public Health and the Methodology of Biomedical Research, Universitat Aut\u00f3noma de Barcelona (UAB), Bellaterra 08193 (Cerdanyola del Vall\u00e8s), Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Diaz", 
        "givenName": "M", 
        "id": "sg:person.0622362671.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622362671.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor; Boston, MA 02115, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "J J", 
        "id": "sg:person.010413204164.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010413204164.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Catal\u00e0 d'Oncologia", 
          "id": "https://www.grid.ac/institutes/grid.418701.b", 
          "name": [
            "Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Av. Gran Via, s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Albero", 
        "givenName": "G", 
        "id": "sg:person.01001145477.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001145477.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge", 
          "id": "https://www.grid.ac/institutes/grid.418284.3", 
          "name": [
            "Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Av. Gran Via, s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Spain", 
            "IDIBELL, CIBERESP, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "de Sanjos\u00e9", 
        "givenName": "S", 
        "id": "sg:person.015452603277.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015452603277.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "International Agency For Research On Cancer", 
          "id": "https://www.grid.ac/institutes/grid.17703.32", 
          "name": [
            "Infections and Cancer Epidemiology Group, Epidemiology and Biology Cluster, International Agency for Research on Cancer (IARC), 150 Cours Albert Thomas, Lyon CEDEX 08 69372, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Clifford", 
        "givenName": "G", 
        "id": "sg:person.0725020131.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725020131.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Catal\u00e0 d'Oncologia", 
          "id": "https://www.grid.ac/institutes/grid.418701.b", 
          "name": [
            "Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Av. Gran Via, s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bosch", 
        "givenName": "F X", 
        "id": "sg:person.012346261072.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012346261072.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor; Boston, MA 02115, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goldie", 
        "givenName": "S J", 
        "id": "sg:person.0670476071.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670476071.20"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.vaccine.2008.04.053", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005773753"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(07)61195-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006780669"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/aje/kwm086", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008224495"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0602-551b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009367418", 
          "https://doi.org/10.1038/nm0602-551b"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0602-551b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009367418", 
          "https://doi.org/10.1038/nm0602-551b"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.11350", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019487370"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603633", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026469206", 
          "https://doi.org/10.1038/sj.bjc.6603633"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0272989x9701700414", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027736952"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0272989x9701700414", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027736952"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1101/gr.1413403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028504395"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2007.05.058", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030912520"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1473-3099(07)70158-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032791221"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.20396", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034601191"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602580", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036129550", 
          "https://doi.org/10.1038/sj.bjc.6602580"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602580", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036129550", 
          "https://doi.org/10.1038/sj.bjc.6602580"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa021641", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036284978"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.11334", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040068020"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1048-891x.2004.014213.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041366331"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmsa044278", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042912539"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmsa044278", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042912539"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1525-1438.2007.00827.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046249780"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1525-1438.2007.00827.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046249780"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2006.05.116", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048761729"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602348", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049714034", 
          "https://doi.org/10.1038/sj.bjc.6602348"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602348", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049714034", 
          "https://doi.org/10.1038/sj.bjc.6602348"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1478-7954-5-11", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051176999", 
          "https://doi.org/10.1186/1478-7954-5-11"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6604023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051357369", 
          "https://doi.org/10.1038/sj.bjc.6604023"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074950205", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077349395", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-07", 
    "datePublishedReg": "2008-07-01", 
    "description": "Cervical cancer is a leading cause of cancer death among women in low-income countries, with approximately 25% of cases worldwide occurring in India. We estimated the potential health and economic impact of different cervical cancer prevention strategies. After empirically calibrating a cervical cancer model to country-specific epidemiologic data, we projected cancer incidence, life expectancy, and lifetime costs (I$2005), and calculated incremental cost-effectiveness ratios (I$/YLS) for the following strategies: pre-adolescent vaccination of girls before age 12, screening of women over age 30, and combined vaccination and screening. Screening differed by test (cytology, visual inspection, HPV DNA testing), number of clinical visits (1, 2 or 3), frequency (1 x , 2 x , 3 x per lifetime), and age range (35-45). Vaccine efficacy, coverage, and costs were varied in sensitivity analyses. Assuming 70% coverage, mean reduction in lifetime cancer risk was 44% (range, 28-57%) with HPV 16,18 vaccination alone, and 21-33% with screening three times per lifetime. Combining vaccination and screening three times per lifetime provided a mean reduction of 56% (vaccination plus 3-visit conventional cytology) to 63% (vaccination plus 2-visit HPV DNA testing). At a cost per vaccinated girl of I$10 (per dose cost of $2), pre-adolescent vaccination followed by screening three times per lifetime using either VIA or HPV DNA testing, would be considered cost-effective using the country's per capita gross domestic product (I$3452) as a threshold. In India, if high coverage of pre-adolescent girls with a low-cost HPV vaccine that provides long-term protection is achievable, vaccination followed by screening three times per lifetime is expected to reduce cancer deaths by half, and be cost-effective.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.bjc.6604462", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.6582558", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "99"
      }
    ], 
    "name": "Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India", 
    "pagination": "6604462", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b539f7c8dd8abe251c101f8a73bc7ce0043c6ac9cfeee2f51924002370ad7091"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18612311"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6604462"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1038043563"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6604462", 
      "https://app.dimensions.ai/details/publication/pub.1038043563"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:45", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8681_00000425.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.nature.com/articles/6604462"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604462'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604462'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604462'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604462'


 

This table displays all metadata directly associated to this object as RDF triples.

266 TRIPLES      21 PREDICATES      68 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6604462 schema:about N198a2e832a724344950d78bfc3054a3b
2 N3ef96933ca69406ea0482e160d142b5f
3 N42af61268a5449a48cc5e34656369114
4 N4a833deb99154756826177457a11206d
5 N58fc67523ec249ffb494288248b76f85
6 N6f8cddc27c2b4a8db097063e1391be04
7 N74945154b9694badbc56356d1add4a60
8 N8cbba44c311043deb506b2d5b7a756f6
9 N8f1a56a159184d61a001757a2517b01b
10 N8f858ec5c7e04a0298b9e5a17a0d9827
11 N8ffff797248748f08c9c37a7bc6431f2
12 Nb7fee4ba6317402bae9c49e7cc9e9577
13 Nc8a6c7d83c69408bbeb335661d18b023
14 Nc8fb9b35f0784c5c862f135f75e8b0c2
15 Ned72c82d02e2442085b4997263bada3e
16 Nf9563761282e45e8b11622abedae7239
17 anzsrc-for:11
18 anzsrc-for:1117
19 schema:author Nabd5c478ba0d4df78b4c365bf6523e87
20 schema:citation sg:pub.10.1038/nm0602-551b
21 sg:pub.10.1038/sj.bjc.6602348
22 sg:pub.10.1038/sj.bjc.6602580
23 sg:pub.10.1038/sj.bjc.6603633
24 sg:pub.10.1038/sj.bjc.6604023
25 sg:pub.10.1186/1478-7954-5-11
26 https://app.dimensions.ai/details/publication/pub.1074950205
27 https://app.dimensions.ai/details/publication/pub.1077349395
28 https://doi.org/10.1002/ijc.11334
29 https://doi.org/10.1002/ijc.11350
30 https://doi.org/10.1002/ijc.20396
31 https://doi.org/10.1016/j.vaccine.2006.05.116
32 https://doi.org/10.1016/j.vaccine.2007.05.058
33 https://doi.org/10.1016/j.vaccine.2008.04.053
34 https://doi.org/10.1016/s0140-6736(07)61195-7
35 https://doi.org/10.1016/s1473-3099(07)70158-5
36 https://doi.org/10.1056/nejmoa021641
37 https://doi.org/10.1056/nejmsa044278
38 https://doi.org/10.1093/aje/kwm086
39 https://doi.org/10.1101/gr.1413403
40 https://doi.org/10.1111/j.1048-891x.2004.014213.x
41 https://doi.org/10.1111/j.1525-1438.2007.00827.x
42 https://doi.org/10.1177/0272989x9701700414
43 schema:datePublished 2008-07
44 schema:datePublishedReg 2008-07-01
45 schema:description Cervical cancer is a leading cause of cancer death among women in low-income countries, with approximately 25% of cases worldwide occurring in India. We estimated the potential health and economic impact of different cervical cancer prevention strategies. After empirically calibrating a cervical cancer model to country-specific epidemiologic data, we projected cancer incidence, life expectancy, and lifetime costs (I$2005), and calculated incremental cost-effectiveness ratios (I$/YLS) for the following strategies: pre-adolescent vaccination of girls before age 12, screening of women over age 30, and combined vaccination and screening. Screening differed by test (cytology, visual inspection, HPV DNA testing), number of clinical visits (1, 2 or 3), frequency (1 x , 2 x , 3 x per lifetime), and age range (35-45). Vaccine efficacy, coverage, and costs were varied in sensitivity analyses. Assuming 70% coverage, mean reduction in lifetime cancer risk was 44% (range, 28-57%) with HPV 16,18 vaccination alone, and 21-33% with screening three times per lifetime. Combining vaccination and screening three times per lifetime provided a mean reduction of 56% (vaccination plus 3-visit conventional cytology) to 63% (vaccination plus 2-visit HPV DNA testing). At a cost per vaccinated girl of I$10 (per dose cost of $2), pre-adolescent vaccination followed by screening three times per lifetime using either VIA or HPV DNA testing, would be considered cost-effective using the country's per capita gross domestic product (I$3452) as a threshold. In India, if high coverage of pre-adolescent girls with a low-cost HPV vaccine that provides long-term protection is achievable, vaccination followed by screening three times per lifetime is expected to reduce cancer deaths by half, and be cost-effective.
46 schema:genre research_article
47 schema:inLanguage en
48 schema:isAccessibleForFree true
49 schema:isPartOf N8b173f40cede4479831d786a14997d2b
50 Nd21bda5dffbf4e69a1ef0f5c2c77250e
51 sg:journal.1017082
52 schema:name Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India
53 schema:pagination 6604462
54 schema:productId N0e78f494000a4ccfb28265b3a8bfa3e7
55 N2b9d41711c1e4e86a4f9bd5ace72f4d4
56 N6ee13e25f20f495baf4d6158afac0a0a
57 N95ed13b1a96746f7a4ac50019ec98e20
58 Nca380491661d40648f1e711ea112cf7f
59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038043563
60 https://doi.org/10.1038/sj.bjc.6604462
61 schema:sdDatePublished 2019-04-10T19:45
62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
63 schema:sdPublisher Ndb44db326cbb430bbbf452da58e2752b
64 schema:url http://www.nature.com/articles/6604462
65 sgo:license sg:explorer/license/
66 sgo:sdDataset articles
67 rdf:type schema:ScholarlyArticle
68 N08c202b3227045d5a7045d5323f93f1a rdf:first sg:person.01001145477.44
69 rdf:rest Nb78f276b20ec4548a9464006a458ec16
70 N0e78f494000a4ccfb28265b3a8bfa3e7 schema:name nlm_unique_id
71 schema:value 0370635
72 rdf:type schema:PropertyValue
73 N198a2e832a724344950d78bfc3054a3b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Models, Economic
75 rdf:type schema:DefinedTerm
76 N2b9d41711c1e4e86a4f9bd5ace72f4d4 schema:name dimensions_id
77 schema:value pub.1038043563
78 rdf:type schema:PropertyValue
79 N3ef96933ca69406ea0482e160d142b5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Mass Screening
81 rdf:type schema:DefinedTerm
82 N42af61268a5449a48cc5e34656369114 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Human papillomavirus 16
84 rdf:type schema:DefinedTerm
85 N4a833deb99154756826177457a11206d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Stochastic Processes
87 rdf:type schema:DefinedTerm
88 N58fc67523ec249ffb494288248b76f85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Human papillomavirus 18
90 rdf:type schema:DefinedTerm
91 N6ee13e25f20f495baf4d6158afac0a0a schema:name readcube_id
92 schema:value b539f7c8dd8abe251c101f8a73bc7ce0043c6ac9cfeee2f51924002370ad7091
93 rdf:type schema:PropertyValue
94 N6f8cddc27c2b4a8db097063e1391be04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Cost-Benefit Analysis
96 rdf:type schema:DefinedTerm
97 N74945154b9694badbc56356d1add4a60 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Uterine Cervical Neoplasms
99 rdf:type schema:DefinedTerm
100 N8b173f40cede4479831d786a14997d2b schema:issueNumber 2
101 rdf:type schema:PublicationIssue
102 N8cbba44c311043deb506b2d5b7a756f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name India
104 rdf:type schema:DefinedTerm
105 N8ea9b75ba40d47c68a968c4a1ba4cb9b rdf:first sg:person.0670476071.20
106 rdf:rest rdf:nil
107 N8f1a56a159184d61a001757a2517b01b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Vaccination
109 rdf:type schema:DefinedTerm
110 N8f858ec5c7e04a0298b9e5a17a0d9827 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Risk Factors
112 rdf:type schema:DefinedTerm
113 N8ffff797248748f08c9c37a7bc6431f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Humans
115 rdf:type schema:DefinedTerm
116 N9344a19823b34ed7bced201ed3db0df0 schema:name Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor; Boston, MA 02115, USA
117 rdf:type schema:Organization
118 N95ed13b1a96746f7a4ac50019ec98e20 schema:name doi
119 schema:value 10.1038/sj.bjc.6604462
120 rdf:type schema:PropertyValue
121 Nabd5c478ba0d4df78b4c365bf6523e87 rdf:first sg:person.0622362671.40
122 rdf:rest Nfd2c49ad4fe4457eb6a260fe6a4ab853
123 Nb5d5658c9d1a4b4abbca1a09a86884ed schema:name Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor; Boston, MA 02115, USA
124 rdf:type schema:Organization
125 Nb78f276b20ec4548a9464006a458ec16 rdf:first sg:person.015452603277.16
126 rdf:rest Nd13b3fcea25d4198ad4efaaa3dfa8c25
127 Nb7fee4ba6317402bae9c49e7cc9e9577 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Papillomavirus Vaccines
129 rdf:type schema:DefinedTerm
130 Nc8a6c7d83c69408bbeb335661d18b023 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Papillomavirus Infections
132 rdf:type schema:DefinedTerm
133 Nc8fb9b35f0784c5c862f135f75e8b0c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name DNA, Viral
135 rdf:type schema:DefinedTerm
136 Nca380491661d40648f1e711ea112cf7f schema:name pubmed_id
137 schema:value 18612311
138 rdf:type schema:PropertyValue
139 Nd13b3fcea25d4198ad4efaaa3dfa8c25 rdf:first sg:person.0725020131.22
140 rdf:rest Ndb2546d951544c3f93d66cdf78cbb800
141 Nd21bda5dffbf4e69a1ef0f5c2c77250e schema:volumeNumber 99
142 rdf:type schema:PublicationVolume
143 Ndb2546d951544c3f93d66cdf78cbb800 rdf:first sg:person.012346261072.25
144 rdf:rest N8ea9b75ba40d47c68a968c4a1ba4cb9b
145 Ndb44db326cbb430bbbf452da58e2752b schema:name Springer Nature - SN SciGraph project
146 rdf:type schema:Organization
147 Ned72c82d02e2442085b4997263bada3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Female
149 rdf:type schema:DefinedTerm
150 Nf9563761282e45e8b11622abedae7239 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Models, Statistical
152 rdf:type schema:DefinedTerm
153 Nfd2c49ad4fe4457eb6a260fe6a4ab853 rdf:first sg:person.010413204164.20
154 rdf:rest N08c202b3227045d5a7045d5323f93f1a
155 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
156 schema:name Medical and Health Sciences
157 rdf:type schema:DefinedTerm
158 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
159 schema:name Public Health and Health Services
160 rdf:type schema:DefinedTerm
161 sg:grant.6582558 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.bjc.6604462
162 rdf:type schema:MonetaryGrant
163 sg:journal.1017082 schema:issn 0007-0920
164 1532-1827
165 schema:name British Journal of Cancer
166 rdf:type schema:Periodical
167 sg:person.01001145477.44 schema:affiliation https://www.grid.ac/institutes/grid.418701.b
168 schema:familyName Albero
169 schema:givenName G
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001145477.44
171 rdf:type schema:Person
172 sg:person.010413204164.20 schema:affiliation Nb5d5658c9d1a4b4abbca1a09a86884ed
173 schema:familyName Kim
174 schema:givenName J J
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010413204164.20
176 rdf:type schema:Person
177 sg:person.012346261072.25 schema:affiliation https://www.grid.ac/institutes/grid.418701.b
178 schema:familyName Bosch
179 schema:givenName F X
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012346261072.25
181 rdf:type schema:Person
182 sg:person.015452603277.16 schema:affiliation https://www.grid.ac/institutes/grid.418284.3
183 schema:familyName de Sanjosé
184 schema:givenName S
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015452603277.16
186 rdf:type schema:Person
187 sg:person.0622362671.40 schema:affiliation https://www.grid.ac/institutes/grid.7080.f
188 schema:familyName Diaz
189 schema:givenName M
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622362671.40
191 rdf:type schema:Person
192 sg:person.0670476071.20 schema:affiliation N9344a19823b34ed7bced201ed3db0df0
193 schema:familyName Goldie
194 schema:givenName S J
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670476071.20
196 rdf:type schema:Person
197 sg:person.0725020131.22 schema:affiliation https://www.grid.ac/institutes/grid.17703.32
198 schema:familyName Clifford
199 schema:givenName G
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725020131.22
201 rdf:type schema:Person
202 sg:pub.10.1038/nm0602-551b schema:sameAs https://app.dimensions.ai/details/publication/pub.1009367418
203 https://doi.org/10.1038/nm0602-551b
204 rdf:type schema:CreativeWork
205 sg:pub.10.1038/sj.bjc.6602348 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049714034
206 https://doi.org/10.1038/sj.bjc.6602348
207 rdf:type schema:CreativeWork
208 sg:pub.10.1038/sj.bjc.6602580 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036129550
209 https://doi.org/10.1038/sj.bjc.6602580
210 rdf:type schema:CreativeWork
211 sg:pub.10.1038/sj.bjc.6603633 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026469206
212 https://doi.org/10.1038/sj.bjc.6603633
213 rdf:type schema:CreativeWork
214 sg:pub.10.1038/sj.bjc.6604023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051357369
215 https://doi.org/10.1038/sj.bjc.6604023
216 rdf:type schema:CreativeWork
217 sg:pub.10.1186/1478-7954-5-11 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051176999
218 https://doi.org/10.1186/1478-7954-5-11
219 rdf:type schema:CreativeWork
220 https://app.dimensions.ai/details/publication/pub.1074950205 schema:CreativeWork
221 https://app.dimensions.ai/details/publication/pub.1077349395 schema:CreativeWork
222 https://doi.org/10.1002/ijc.11334 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040068020
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1002/ijc.11350 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019487370
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1002/ijc.20396 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034601191
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1016/j.vaccine.2006.05.116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048761729
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1016/j.vaccine.2007.05.058 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030912520
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1016/j.vaccine.2008.04.053 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005773753
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/s0140-6736(07)61195-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006780669
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/s1473-3099(07)70158-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032791221
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1056/nejmoa021641 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036284978
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1056/nejmsa044278 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042912539
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1093/aje/kwm086 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008224495
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1101/gr.1413403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028504395
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1111/j.1048-891x.2004.014213.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1041366331
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1111/j.1525-1438.2007.00827.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1046249780
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1177/0272989x9701700414 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027736952
251 rdf:type schema:CreativeWork
252 https://www.grid.ac/institutes/grid.17703.32 schema:alternateName International Agency For Research On Cancer
253 schema:name Infections and Cancer Epidemiology Group, Epidemiology and Biology Cluster, International Agency for Research on Cancer (IARC), 150 Cours Albert Thomas, Lyon CEDEX 08 69372, France
254 rdf:type schema:Organization
255 https://www.grid.ac/institutes/grid.418284.3 schema:alternateName Institut d'Investigació Biomédica de Bellvitge
256 schema:name IDIBELL, CIBERESP, Barcelona, Spain
257 Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Av. Gran Via, s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Spain
258 rdf:type schema:Organization
259 https://www.grid.ac/institutes/grid.418701.b schema:alternateName Institut Català d'Oncologia
260 schema:name Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Av. Gran Via, s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Spain
261 rdf:type schema:Organization
262 https://www.grid.ac/institutes/grid.7080.f schema:alternateName Autonomous University of Barcelona
263 schema:name Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor; Boston, MA 02115, USA
264 Department of Paediatrics, Obstetrics, Gynaecology and Preventive Medicine, Program in Public Health and the Methodology of Biomedical Research, Universitat Autónoma de Barcelona (UAB), Bellaterra 08193 (Cerdanyola del Vallès), Spain
265 Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Av. Gran Via, s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Spain
266 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...